Suppr超能文献

在卢旺达的“全面治疗”中,何时启动抗逆转录病毒治疗(ART)过早?以及在参与艾滋病毒护理方面的挑战:一项定性研究。

How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.

机构信息

Division of General Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America.

Clinical Education and Research Division, Rwanda Military Hospital, Kigali, Rwanda.

出版信息

PLoS One. 2021 May 13;16(5):e0251645. doi: 10.1371/journal.pone.0251645. eCollection 2021.

Abstract

INTRODUCTION

HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomatic, and they may view the relative benefits and risks of ART differently than those initiating at more advanced disease stages. To date, patient perspectives of initiating care under Treat All in sub-Saharan Africa have not been well described.

METHODS

From September 2018 to March 2019, we conducted individual, semi-structured, qualitative interviews with 37 patients receiving HIV care in two health centers in Kigali, Rwanda. Data were analyzed using a mixed deductive and inductive thematic analysis approach to describe perceived barriers to, facilitators of and acceptability of initiating and adhering to ART rapidly under Treat All.

RESULTS

Of 37 participants, 27 were women and the median age was 31 years. Participants described feeling traumatized and overwhelmed by their HIV diagnosis, resulting in difficulty accepting their HIV status. Most were prescribed ART soon after diagnosis, yet fear of lifelong medication and severe side effects in the immediate period after initiating ART led to challenges adhering to therapy. Moreover, because many PLWH initiated ART while healthy, taking medications and attending appointments were visible signals of HIV status and highly stigmatizing. Nonetheless, many participants expressed enthusiasm for Treat All as a program that improved health as well as health equity.

CONCLUSION

For newly-diagnosed PLWH in Rwanda, initiating ART rapidly under Treat All presents logistical and emotional challenges despite the perceived benefits. Our findings suggest that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART.

摘要

简介

HIV 治疗指南建议所有 HIV 感染者(PLWH)在诊断后尽快开始抗逆转录病毒治疗(ART)(即治即服)。随着治即服的广泛实施,越来越多的 PLWH 在无症状时开始接受 ART,他们可能会以不同的方式看待 ART 的相对益处和风险,与那些在更晚期疾病阶段开始治疗的人不同。迄今为止,撒哈拉以南非洲地区在治即服下开始治疗的患者观点尚未得到很好的描述。

方法

2018 年 9 月至 2019 年 3 月,我们在卢旺达基加利的两个卫生中心对 37 名接受 HIV 护理的患者进行了个体、半结构化、定性访谈。使用混合演绎和归纳主题分析方法分析数据,以描述在治即服下快速开始和坚持接受 ART 的障碍、促进因素和可接受性。

结果

37 名参与者中,27 名为女性,中位年龄为 31 岁。参与者描述了他们被 HIV 诊断所带来的创伤和不知所措,导致难以接受他们的 HIV 状况。大多数人在诊断后很快就开始接受 ART,但对终身服药和开始治疗后立即出现严重副作用的恐惧,导致治疗依从性受到挑战。此外,由于许多 PLWH 在健康时开始接受 ART,服药和就诊成为 HIV 状况的明显信号,导致高度污名化。尽管如此,许多参与者对治即服计划表示热情,认为该计划改善了健康状况和健康公平。

结论

对于卢旺达新诊断的 PLWH,尽管有好处,但在治即服下快速开始接受 ART 存在后勤和情感方面的挑战。我们的研究结果表明,要优化治即服下的早期 HIV 护理参与,需要早期和持续的干预,以减少创伤和污名化,促进 ART 的个体和社区效益。

相似文献

1
How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
PLoS One. 2021 May 13;16(5):e0251645. doi: 10.1371/journal.pone.0251645. eCollection 2021.
2
Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study.
BMC Public Health. 2023 Sep 19;23(1):1817. doi: 10.1186/s12889-023-16752-y.

引用本文的文献

1
Adherence, perceptions and knowledge of an HIV PMTCT programme: A mother-baby pair study.
South Afr J HIV Med. 2025 Jan 28;26(1):1648. doi: 10.4102/sajhivmed.v26i1.1648. eCollection 2025.
4
Is the Differentiated Service Delivery Model Suited to the Needs of People Living with HIV in Rwanda?
AIDS Behav. 2024 Sep;28(9):2941-2949. doi: 10.1007/s10461-024-04376-1. Epub 2024 May 23.
6
Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
PLoS Med. 2024 Mar 18;21(3):e1004367. doi: 10.1371/journal.pmed.1004367. eCollection 2024 Mar.
7
Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
PLoS One. 2024 Feb 12;19(2):e0298021. doi: 10.1371/journal.pone.0298021. eCollection 2024.
8
Association Between Clinical Encounter Frequency and HIV-Related Stigma Among Newly-Diagnosed People Living with HIV in Rwanda.
AIDS Behav. 2024 Apr;28(4):1390-1400. doi: 10.1007/s10461-023-04226-6. Epub 2023 Dec 19.
9
Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
PLoS One. 2023 Nov 15;18(11):e0292740. doi: 10.1371/journal.pone.0292740. eCollection 2023.
10
Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study.
BMC Public Health. 2023 Sep 19;23(1):1817. doi: 10.1186/s12889-023-16752-y.

本文引用的文献

7
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
N Engl J Med. 2020 Mar 19;382(12):1112-1123. doi: 10.1056/NEJMoa1904398. Epub 2020 Mar 4.
9
Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data.
PLoS One. 2020 Jan 14;15(1):e0227572. doi: 10.1371/journal.pone.0227572. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验